Rockefeller Capital Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Rockefeller Capital Management's UTHR Position: Q3 2026 in Review
Rockefeller Capital Management increased its United Therapeutics (UTHR) stake by 6.7% in Q3 2026, buying an estimated $52.2K and bringing the position to 1,607 shares worth $871K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.
Rockefeller Capital Management first reported a position in UTHR in Q1 2019 and has held it in 21 quarters since. The position peaked at $926K in Q1 2026. 838 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Rockefeller Capital Management held 1,607 shares of United Therapeutics worth $871K as of Q3 2026.
- Rockefeller Capital Management bought 101 United Therapeutics shares in Q3 2026, an estimated $52.2K.
- United Therapeutics made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #1825 holding.
- Rockefeller Capital Management first reported a position in United Therapeutics in Q1 2019 and has held it in 21 quarters since.
- Rockefeller Capital Management's United Therapeutics position peaked at $926K in Q1 2026.
- 838 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.